News
The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...
11h
HealthDay on MSNADA: Insulin Efsitora Noninferior to Glargine for Reducing HbA1c in Adults With Type 2 DiabetesOnce-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated ...
VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...
2d
Health and Me on MSNType 1 Diabetes Patients May Not Need Insulin To Survive With New Cell Treatment: StudyDiabetes affects many people in the world, type 1 diabetes being a condition that can affect anyone, causing them to be on ...
Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, gathered with ...
1d
Everyday Health on MSNDitching Diet Soda Tied to Weight Loss and Higher Chance of Diabetes RemissionWomen with diabetes who were overweight or had obesity lost more weight and had greater odds of diabetes remission when ...
Results presented at the 85th Scientific Sessions of the American Diabetes Association in Chicago highlight the potential for ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...
Want to lose weight and reverse type 2 diabetes? Trade diet soda for a tall glass of water, a new small-scale study argues.
All 3 doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results